The Experts below are selected from a list of 1287 Experts worldwide ranked by ideXlab platform
Mert Ali - One of the best experts on this subject based on the ideXlab platform.
-
Erratum: An unnoticed origin of fever: Periapical Tooth Abscess - Three case reports and literature review
NLM (Medline), 2017Co-Authors: Arslan Ferhat, Karagöz Ergenekon, Yiğit Arslan Birsen, Mert AliAbstract:Erratum Following publication of the Original article An unnoticed origin of fever: Periapical Tooth Abscess - Three case reports and literature review (Infez. Med., volume 24, issue 1, pages 67-70, year 2016) We became aware that some authors were missing from the title page The correct list of the authors and affiliations is the following An unnoticed origin of fever: Periapical Tooth Abscess - Three case reports and literature review Ferhat Arslan1, Ergenekon Karagöz2, Mesut Yilmaz1, Ayse Batirel3, Birsen Yigit Arslan4, Nedim Ozer5, Nadir Alpay6, Ali Mert1 1Department of Infectious Diseases and Clinical Microbiology, Istanbul Medipol University Hospital, Istanbul, Turkey 2Department of Infectious Diseases and Clinical Microbiology, Van Military Hospital, Van, Turkey 3Department of Infectious Diseases and Clinical Microbiology, Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey 4Department of Anesthesiology and Reanimation, Esenyurt State Hospital, Istanbul, Turkey 5Department of Dentistry, Istanbul Medipol University Hospital, Istanbul, Turkey 6Department of Internal Medicine, Istanbul Medipol University Hospital, Istanbul, Turkey
Ali Mert - One of the best experts on this subject based on the ideXlab platform.
-
an unnoticed origin of fever periapical Tooth Abscess three case reports and literature review
Le infezioni in medicina : rivista periodica di eziologia epidemiologia diagnostica clinica e terapia delle patologie infettive, 2016Co-Authors: Ferhat Arslan, Ergenekon Karagoz, Birsen Yigit Arslan, Ali MertAbstract:Dental infections may lead to severe local or systemic infections such as endocarditis, brain Abscesses and mediastinitis. Fever may be the only symptom. We aim to highlight dental/odontogenic Abscesses as the occult source of unexplained fever by reporting on three cases and reviewing the relevant literature. Early dental evaluation and referral of patients with persistent fever (even without any oral symptoms) to a dentist plays a critical role in preventing unnecessary, time-consuming and high-cost further diagnostic tests and invasive procedures. A simple panoramic dental radiography may suffice to establish the diagnosis.
Arslan Ferhat - One of the best experts on this subject based on the ideXlab platform.
-
Erratum: An unnoticed origin of fever: Periapical Tooth Abscess - Three case reports and literature review
NLM (Medline), 2017Co-Authors: Arslan Ferhat, Karagöz Ergenekon, Yiğit Arslan Birsen, Mert AliAbstract:Erratum Following publication of the Original article An unnoticed origin of fever: Periapical Tooth Abscess - Three case reports and literature review (Infez. Med., volume 24, issue 1, pages 67-70, year 2016) We became aware that some authors were missing from the title page The correct list of the authors and affiliations is the following An unnoticed origin of fever: Periapical Tooth Abscess - Three case reports and literature review Ferhat Arslan1, Ergenekon Karagöz2, Mesut Yilmaz1, Ayse Batirel3, Birsen Yigit Arslan4, Nedim Ozer5, Nadir Alpay6, Ali Mert1 1Department of Infectious Diseases and Clinical Microbiology, Istanbul Medipol University Hospital, Istanbul, Turkey 2Department of Infectious Diseases and Clinical Microbiology, Van Military Hospital, Van, Turkey 3Department of Infectious Diseases and Clinical Microbiology, Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey 4Department of Anesthesiology and Reanimation, Esenyurt State Hospital, Istanbul, Turkey 5Department of Dentistry, Istanbul Medipol University Hospital, Istanbul, Turkey 6Department of Internal Medicine, Istanbul Medipol University Hospital, Istanbul, Turkey
R V Tauxe - One of the best experts on this subject based on the ideXlab platform.
-
wound botulism in a patient with a Tooth Abscess case report and review
Clinical Infectious Diseases, 1993Co-Authors: J T Weber, H C Goodpasture, H Alexander, S B Werner, Charles L Hatheway, R V TauxeAbstract:We describe a case of wound botulism associated with a Tooth Abscess in a 5-year-old boy. We reviewed the literature and reports to the Centers for Disease Control and Prevention (Atlanta) of laboratory-confirmed cases of wound botulism. From 1943 through 1990, 47 cases were reported. Type A botulinus toxin was identified in 32 cases, type B in 13, types A and B in 1, and an unknown type in 1. Botulism was associated with wounds from trauma, use of injectable drugs, and surgery. Sinusitis after use of intranasal cocaine has also been associated with botulism. Treatment for wound botulism includes prompt debridement of the wound for eliminating anaerobic conditions, intensive care, and treatment with antitoxin.
Jiang Shao - One of the best experts on this subject based on the ideXlab platform.
-
safety and efficacy of ledipasvir sofosbuvir with or without ribavirin for chronic hepatitis c in children ages 6 11
Hepatology, 2018Co-Authors: Karen F. Murray, Kathryn Kersey, William F. Balistreri, Sanjay Bansal, Benedetta Massetto, Suzanne Whitworth, Helen M Evans, Regino P Gonzalezperalta, Jessica Wen, Jiang ShaoAbstract:Currently, there are no interferon-free treatments available for hepatitis C virus (HCV)-infected patients younger than 12 years. We evaluated the safety and effectiveness of the all-oral regimen ledipasvir-sofosbuvir ± ribavirin in HCV-infected children aged 6 to <12 years. In an open-label study, patients aged 6 to <12 years received ledipasvir 45 mg-sofosbuvir 200 mg as two fixed-dose combination tablets 22.5/100 mg once daily, with or without ribavirin, for 12 or 24 weeks, depending on HCV genotype and cirrhosis status. The primary efficacy endpoint was sustained virologic response 12 weeks after therapy (SVR12). Twelve patients underwent intensive pharmacokinetic sampling to confirm the appropriateness of the ledipasvir and sofosbuvir dosages. Ninety-two patients were enrolled (88 genotype 1, 2 genotype 3, and 2 genotype 4), with a median age of 9 years (range, 6-11). Most were perinatally infected (97%) and treatment-naive (78%). Two were confirmed to have cirrhosis, while the degree of fibrosis was unknown in 55 patients. The overall SVR12 rate was 99% (91/92; 95% confidence interval, 94%-100%). The single patient not reaching SVR relapsed 4 weeks after completing 12 weeks of treatment. The most common adverse events were headache and pyrexia. One patient had three serious adverse events, which were considered to be not related to study treatment: Tooth Abscess, abdominal pain, and gastroenteritis. The area under the concentration-time curve and maximum concentration values for sofosbuvir, its primary metabolite GS-331007, and ledipasvir were within predefined pharmacokinetic equivalence boundaries (50%-200%) compared to values in adults in phase 2/3 of the ledipasvir and sofosbuvir studies. Conclusion: Ledipasvir-sofosbuvir was well tolerated and highly effective in children 6 to <12 years old with chronic HCV.